26 March 2018 - Pharmaceutical industry representatives have applauded the decision to progress Brexit negotiations to the next phase, with the UK and EU having agreed the terms of the transition period.

The 21-month transitional period will run from March 29, 2019 to the end of 2020, during which time rights for EU citizens arriving in the UK will remain as per the status quo, as will those of UK citizens living in Europe.

During the period the UK will be allowed to negotiate new trade deals while remaining part of any EU trade deals already in place.

Read Pharma Times article